US$ 28.50
retatrutide type 2 diabetes phase 2 weight loss 2024 π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No plateau β curve still descending Retatrutide produces up to 30.3%
Description
Retatrutide Research Highlights (2026) Obesity Research A phase 2 trial in 338 adults with obesity or overweight showed dose-dependent weight loss

When asked what theyd be willing to give up to afford a GLP-1 prescription, 38% said dining out or takeout, 24% said travel or leisure, and 22% said streaming subscriptions
The nuanced version of the verdict: For pure fat loss efficacy: Retatrutide leads clearly

They, you know, collected data from, like, over 600,000 veterans

[DOI] [PubMed] [Google Scholar] 3.van Raalte DH, et al

10.1016/S0140-6736(21)01751-7 [DOI] [PubMed] [Google Scholar] 76
